LYTIR

Company · ELTP

ELITE PHARMACEUTICALS INC /NV/

ELTP is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($35K); 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $35K in total; Insider sales: $0 in total.Aug: Insider purchases $9KOct: Insider purchases $26KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $35KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Barry H. Dash bought on 2 days latest Oct 9, 2026 bought $35K
Every trade (2)
  1. BUYBarry H. Dash bought Oct 9, 2026 100,000 shares filing $26K
  2. BUYBarry H. Dash bought Aug 19, 2026 30,000 shares filing $9K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers; Regulation FD disclosure filing Nov 3, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.